Scarica l'app Stockscreener
1.20
30.43%
0.28
Dopo l'orario di chiusura:
1.23
0.03
+2.50%
Predictive Oncology Inc Borsa (POAI) Ultime notizie
OSUR Stock Surges Over 5% Amid Market Activity - GuruFocus.com
Intelligent Bio Solutions (NASDAQ:INBS) Stock Quotes, Forecast and News Summary - Benzinga
Artificial Intelligence in Oncology Market to Hit US$ 11.52 Billion by 2030 with 29.4% CAGR | MarketsandMarkets - The Malaysian Reserve
Artificial Intelligence in Oncology Market to Hit US$ 11.52 Billion by 2030 with 29.4% CAGR | MarketsandMarkets™ - PR Newswire UK
BullFrog AI Announces Appointment of Chief Financial Officer - The Manila Times
Addressing the oncological ‘other’: How predictive analysis can shift the research imbalance - pharmaphorum
Head to Head Contrast: Predictive Oncology (NASDAQ:POAI) vs. Avitar (OTCMKTS:AVTI) - Defense World
Certis Oncology Solutions Unveils CertisOI Assistant™ - Business Wire
Predictive Oncology explores strategic options to enhance value By Investing.com - Investing.com Canada
Predictive Oncology explores strategic options to enhance value - Investing.com India
Predictive Oncology engaged in ‘productive discussions’ with multiple parties - TipRanks
Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives - The Manila Times
Predictive Oncology Advances Strategic Sale Talks, Touts 150K+ Tumor Sample Portfolio - StockTitan
Predictive Oncology Inc.'s (NASDAQ:POAI) Path To Profitability - Simply Wall St
Bluejay Diagnostics (NASDAQ:BJDX) Stock Quotes, Forecast and News Summary - Benzinga
Predictive Oncology faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com South Africa
Predictive Oncology faces Nasdaq delisting over equity shortfall - Investing.com India
Predictive Oncology Receives Notice of Non-Compliance from Nasdaq - Defense World
Predictive Oncology Inc. Issues Press Release Detailing Financial Results for Q3 2024Predictive Oncology Inc., a leading biopharmaceutical company, released a pivotal press release detailing its financial results for the quarter ending September 30 - Defense World
This SolarEdge Technologies Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews
Predictive Oncology downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
Predictive Oncology Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Predictive Oncology Inc. Reports Q3 2024 Earnings - TipRanks
U.S. STOCKS BankUnited, Natera, Adaptimmune - XM
Artificial Intelligence in Drug Discovery Market Expecting Huge Demand in Upcoming Years - openPR
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update - The Manila Times
Predictive Oncology Reports Q3 Loss, Launches Strategic Review Amid 49% Revenue Drop | POAI Stock News - StockTitan
Predictive Oncology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
International Conference on the Crystallization of Biological Macromolecules - Arizona State University (ASU)
American Well Corporation (AMWL) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets™ - PR Newswire UK
Some Major Key Players In The Genomic Cancer Panel and Profiling Market: - InsightAce Analytic
AngioDynamics (ANGO) Stock Dips Amidst Financial Performance Rev - GuruFocus.com
, a machine learning-based RNA oncology test predicting immunotherapy response - Business Wire
HC Wainwright & Co. Initiates Coverage of Predictive Oncology (POAI) with Buy Recommendation - MSN
Artificial Intelligence in Genomics Market is Estimated to Reach $5.5 Billion By 2032 - 대구포스트
POAI stock touches 52-week low at $0.64 amid market challenges By Investing.com - Investing.com South Africa
Predictive Oncology Inc (POAI) Q2 2024 Earnings Call Highlights: Strategic Advances Amidst ... - Yahoo Finance
POAI stock touches 52-week low at $0.64 amid market challenges - Investing.com
Certis files patent for AI platform to ID predictive cancer biomarkers - BioWorld Online
ODAC votes decisively in support of PD-L1 expression as predictive biomarker for checkpoint inhibitors - The Cancer Letter
HBIO Stock Drops Amidst Market Fluctuations - GuruFocus.com
POAI stock touches 52-week low at $0.74 amid market challenges By Investing.com - Investing.com South Africa
POAI stock touches 52-week low at $0.74 amid market challenges - Investing.com India
BioAI Announces Strategic Partnership with Arbele Bio to advance Predictive AI-Models in Oncology Clinical Trials - PR Newswire
ODAC votes overwhelmingly in support of PD-L1 expression as predictive biomarker for efficacy of checkpoint inhibitors - The Cancer Letter
11 Best AI Penny Stocks Under $10 in 2024 - CoinCodex
Predictive Oncology (NASDAQ:POAI) Shares Pass Below Two Hundred Day Moving Average of $1.42 - Defense World
Payoneer Global (NASDAQ:PAYO) Reaches New 52-Week High at $7.67 - MarketBeat
Strong Market Opportunities For OneStream Amid Rising Demand for AI-Driven Financial Solutions, Analyst Says - Yahoo Finance UK
TD Cowen analysts reiterates a Buy rating for PureCycle Technologies Inc (PCT) - Knox Daily
Prepare Yourself for Liftoff: Pyxis Oncology Inc (PYXS) - SETE News
Paylocity price target raised to $186 from $171 at TD Cowen - TipRanks
Paycor HCM, Inc. (PYCR): Short Seller Sentiment is Bearish on This AI Stock Under $50 - Yahoo Finance UK
ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services from Pets to Humans - Business Wire
2.64%
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):